Epizyme

Biotechnology ResearchMassachusetts, United States201-500 Employees

Epizyme is a biotechnology research company based in Cambridge, Massachusetts, with an employee range of 201 to 500. It concentrates on developing targeted epigenetic medicines for cancer, pursuing novel mechanisms of action directed at hematological malignancies and solid tumors. The company’s research focuses on identifying new targets and advancing small-molecule programs to expand a pipeline of clinical candidates. In August 2022, Ipsen completed the acquisition of Epizyme, and Epizyme now operates as an Ipsen company, expanding Ipsen’s oncology portfolio. More information is available on Epizyme’s website at www.epizyme.com.

Sign up for free to view info

Email Format Employee directory